Hydroxychloroquine Efficacy on Behcet's Disease Thrombosis

Summary

Patients diagnosed with Behcet's disease will be randomized to administeration of hydroxychloroquine. Assessment will be done for the patients at baseline and every one month in the first three months and then quarterly for one year.

Timeline

Start

2018-10-01

Primary completion

2019-08

Completion

2019-10

Drugs

Indications